Dr. Valero utilizes a multidisciplinary approach to the treatment of breast cancer. His research interests include breast neoplasms, unusual histologies, new drug development, minority groups, and clinical trials with angiogenesis. More specifically, his primary focus is in the area of Her-2 neu amplified and ER+ HER-2 normal early, as well as metastatic breast cancer and novel biological agents, the management of patients with locally advanced breast cancer utilizing new biological agents and gene profiling, and clinical research targeting minority populations.